Search
Sight Sciences Inc
SGHTAdd to Watchlist
8.250USD
+0.110+1.35%
Close 08-14 16:00（ET）Quotes delayed by 15 min
451.41MMarket Cap
LossP/E TTM
Forecast
Currency: USD Updated: 2026-08-14The current earnings forecast score of Sight Sciences Inc is 7.75, ranking 121 out of 201 in the Healthcare Equipment & Supplies industry. The average price target is 6.50, with a high of 8.00 and a low of 5.00.
Analyst Rating
Based on
8
analysts
Buy
Current Rating
8.833
Target Price
+8.52%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
109
Total
7
Median
9
Average
Company name
Ratings
Analysts
Sight Sciences Inc
SGHT
8
Stryker Corp
SYK
30
Medtronic PLC
MDT
30
Dexcom Inc
DXCM
30
Abbott Laboratories
ABT
29
Zimmer Biomet Holdings Inc
ZBH
29
1
2
3
...
22
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FAQs
What is Sight Sciences Inc's expected revenue for the next quarter?
Sight Sciences Inc's expected revenue is 23.55M.
What is Sight Sciences Inc's price target?
Analysts forecast that Sight Sciences Inc's price target is USD 6.50, with the highest forecast at USD 8.00 and the lowest forecast at USD 5.00.
How have Sight Sciences IncSGHT's recent earnings per share performed?
The market expectation was USD -0.08, while Sight Sciences IncSGHT's earnings per share (EPS) for the previous quarter was USD -0.24. EPS for the next quarter is expected at USD -0.14.
What is the analyst rating for Sight Sciences Inc?
Based on the ratings of Sight Sciences Inc's stock from 8 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.